These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 19567133)
1. Glioblastoma stem cells resistant to temozolomide-induced autophagy. Fu J; Liu ZG; Liu XM; Chen FR; Shi HL; Pangjesse CS; Ng HK; Chen ZP Chin Med J (Engl); 2009 Jun; 122(11):1255-9. PubMed ID: 19567133 [TBL] [Abstract][Full Text] [Related]
2. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis. Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235 [TBL] [Abstract][Full Text] [Related]
3. Co-expression of Cytoskeletal Protein Adducin 3 and CD133 in Neurospheres and a Temozolomide-resistant Subclone of Glioblastoma. Poon MW; Zhuang JT; Wong ST; Sun S; Zhang XQ; Leung GK Anticancer Res; 2015 Dec; 35(12):6487-95. PubMed ID: 26637861 [TBL] [Abstract][Full Text] [Related]
4. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells. Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897 [TBL] [Abstract][Full Text] [Related]
5. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381 [TBL] [Abstract][Full Text] [Related]
6. Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression. Perazzoli G; Prados J; Ortiz R; Caba O; Cabeza L; Berdasco M; Gónzalez B; Melguizo C PLoS One; 2015; 10(10):e0140131. PubMed ID: 26447477 [TBL] [Abstract][Full Text] [Related]
7. Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype. Fouse SD; Nakamura JL; James CD; Chang S; Costello JF Neuro Oncol; 2014 Mar; 16(3):361-71. PubMed ID: 24311636 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Ulasov IV; Nandi S; Dey M; Sonabend AM; Lesniak MS Mol Med; 2011; 17(1-2):103-12. PubMed ID: 20957337 [TBL] [Abstract][Full Text] [Related]
9. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Liu G; Yuan X; Zeng Z; Tunici P; Ng H; Abdulkadir IR; Lu L; Irvin D; Black KL; Yu JS Mol Cancer; 2006 Dec; 5():67. PubMed ID: 17140455 [TBL] [Abstract][Full Text] [Related]
10. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells. Kim JS; Shin DH; Kim JS J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480 [TBL] [Abstract][Full Text] [Related]
11. High expression of leptin receptor leads to temozolomide resistance with exhibiting stem/progenitor cell features in gliobalastoma. Han G; Wang L; Zhao W; Yue Z; Zhao R; Li Y; Zhou X; Hu X; Liu J Cell Cycle; 2013 Dec; 12(24):3833-40. PubMed ID: 24131927 [TBL] [Abstract][Full Text] [Related]
12. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Das A; Banik NL; Patel SJ; Ray SK Mol Cancer; 2004 Dec; 3(1):36. PubMed ID: 15588281 [TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution. Metellus P; Nanni-Metellus I; Delfino C; Colin C; Tchogandjian A; Coulibaly B; Fina F; Loundou A; Barrie M; Chinot O; Ouafik L; Figarella-Branger D Ann Surg Oncol; 2011 Oct; 18(10):2937-45. PubMed ID: 21479688 [TBL] [Abstract][Full Text] [Related]
14. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma. Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863 [TBL] [Abstract][Full Text] [Related]
15. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma. Lan F; Pan Q; Yu H; Yue X J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372 [TBL] [Abstract][Full Text] [Related]
16. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death. Cheng Y; Sk UH; Zhang Y; Ren X; Zhang L; Huber-Keener KJ; Sun YW; Liao J; Amin S; Sharma AK; Yang JM PLoS One; 2012; 7(4):e35104. PubMed ID: 22496897 [TBL] [Abstract][Full Text] [Related]
17. Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression. Zhao Y; Xiao Z; Chen W; Yang J; Li T; Fan B Mol Med Rep; 2015 Aug; 12(2):2313-22. PubMed ID: 25937029 [TBL] [Abstract][Full Text] [Related]
18. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Lomonaco SL; Finniss S; Xiang C; Decarvalho A; Umansky F; Kalkanis SN; Mikkelsen T; Brodie C Int J Cancer; 2009 Aug; 125(3):717-22. PubMed ID: 19431142 [TBL] [Abstract][Full Text] [Related]
19. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway. Xu P; Zhang G; Hou S; Sha LG Biomed Pharmacother; 2018 Oct; 106():1419-1427. PubMed ID: 30119215 [TBL] [Abstract][Full Text] [Related]
20. Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells-derived exosomes. Liu X; Liu L; Wu A; Huang S; Xu Z; Zhang X; Li Z; Li H; Dong J CNS Neurosci Ther; 2024 Feb; 30(2):e14599. PubMed ID: 38332576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]